IOVA icon

Iovance Biotherapeutics

77 hedge funds and large institutions have $183M invested in Iovance Biotherapeutics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 29 increasing their positions, 17 reducing their positions, and 16 closing their positions.

Holders
77
Holders Change
-5
Holders Change %
-6.1%
% of All Funds
2.05%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
11
Increased
29
Reduced
17
Closed
16
Calls
$2.95M
Puts
$422K
Net Calls
+$2.53M
Net Calls Change
-$3.64M
Name Market Value Shares Shares
Change
Shares
Change %
Barclays
76
Barclays
United Kingdom
$1K 295 -509 -63%
VIA
77
Vident Investment Advisory
Georgia
$898 176,720 +84,567 +92%
PAWC
78
P.A.W. Capital
Connecticut
-200,000 Closed
Nuveen Asset Management
79
Nuveen Asset Management
Illinois
-141,357 Closed
Connor, Clark & Lunn Investment Management (CC&L)
80
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-31,200 Closed
EEG
81
E.E. Geduld
-20,000 Closed
Susquehanna International Group
82
Susquehanna International Group
Pennsylvania
-12,364 Closed
AL
83
Airain Ltd
Guernsey
-10,975 Closed
Bank of America
84
Bank of America
North Carolina
-9,256 Closed
BNP Paribas Financial Markets
85
BNP Paribas Financial Markets
France
-8,924 Closed
US Bancorp
86
US Bancorp
Minnesota
-7,206 Closed
EWM
87
Edge Wealth Management
New York
-3,800 Closed
PAM
88
Panagora Asset Management
Massachusetts
-977 Closed
JG
89
Jefferies Group
New York
-491 Closed
TRCT
90
Tower Research Capital (TRC)
New York
-414 Closed
AFP
91
Ausdal Financial Partners
Iowa
-200 Closed
WAS
92
Winch Advisory Services
Wisconsin
-172 Closed
KCPG
93
Kavar Capital Partners Group
Kansas
-35 Closed
ST
94
Spot Trading
Illinois
PG
95
PEAK6 Group
Illinois
Simplex Trading
96
Simplex Trading
Illinois
Parallax Volatility Advisers
97
Parallax Volatility Advisers
California